Edition:
United States

Syneron Medical Ltd (ELOS.OQ)

ELOS.OQ on NASDAQ Stock Exchange Global Select Market

10.65USD
24 Mar 2017
Change (% chg)

$-0.05 (-0.47%)
Prev Close
$10.70
Open
$10.80
Day's High
$11.00
Day's Low
$10.43
Volume
74,851
Avg. Vol
40,059
52-wk High
$11.20
52-wk Low
$6.21

Latest Key Developments (Source: Significant Developments)

Syneron Medical Q2 non-gaap EPS $0.09
Thursday, 4 Aug 2016 07:00am EDT 

Syneron Medical Reports Second Quarter 2016 Revenue Of $75.0 Million And Non : Gaap eps of $0.09 . Q2 revenue $75 million versus i/b/e/s view $75.7 million . Q2 non-gaap earnings per share $0.09 . Q2 earnings per share view $0.06 -- Thomson Reuters I/B/E/S .Q2 earnings per share $0.03.  Full Article

Syneron Medical Ltd says PicoWay Picosecond laser receives U.S. FDA clearance for ultra-short 785nm wavelength
Monday, 25 Jul 2016 09:00am EDT 

Syneron Medical Ltd :Syneron Candela's Picoway Picosecond laser receives U.S. FDA clearance for ultra-short 785nm wavelength.  Full Article

Syneron Candela says announces FDA clearance of its non-invasive fat destruction device
Monday, 18 Jul 2016 09:00am EDT 

Syneron Medical Ltd : Syneron candela announces fda clearance of high energy ultrashape power for fat destruction .Fda clearance is for non-invasive reduction of abdominal circumference via fat cell destruction.  Full Article

Syneron Medical reports Q1 adj. earnings per share $0.04
Thursday, 19 May 2016 07:22am EDT 

Syneron Medical Ltd : Syneron Medical reports first quarter 2016 revenue of $68.7 million . Q1 non-GAAP earnings per share $0.04 . Q1 revenue $68.7 million versus I/B/E/S view $64.4 million .Q1 earnings per share view $0.01 -- Thomson Reuters I/B/E/S.  Full Article

Syneron Medical Ltd gives Q4 2015 revenue outlook above analysts' estimates
Monday, 11 Jan 2016 04:05pm EST 

Syneron Medical Ltd:Sees Total revenue for Q4 2015 is expected to be in the range of $78 to $79 million.Q4 2015 revenue of $75 mln - Thomson Reuters I/B/E/S.  Full Article

Syneron Medical Ltd's Syneron Candela Announces New FDA Clearance for the CO2RE System
Thursday, 5 Nov 2015 09:00am EST 

Syneron Medical Ltd:Says the US Food and Drug Administration (FDA) has granted numerous additional indications for use of the CO2RE CO2device.Saus This clearance, including more than 90 specific indications in total, significantly expands the business opportunity for CO2RE users for high patient demand treatments.Says new indications for use include gynecology applications (including vaginal treatments), wrinkles, scars, and a wide range of dermatology and plastic surgery indications.  Full Article

Syneron Medical Ltd Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser
Monday, 27 Jul 2015 09:00am EDT 

Syneron Medical Ltd:Says it has received Korean Ministry of Food and Drug Safety (MFDS) regulatory clearance for the PicoWay picosecond laser.Says With this regulatory clearance, the Company can fulfill PicoWay orders from its Korean distribution partner, with additional commercial launch activity in Korea anticipated later in the third quarter 2015.  Full Article

More From Around the Web

BRIEF-Syneron Medical posts Q3 GAAP EPS of $0.02

* Syneron Medical reports third quarter 2016 revenue of $71.5 million